Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Twelve Week, Open Label Extension Study in Patients With Schizophrenia

ClinicalTrials.gov ID: NCT01566162

Public ClinicalTrials.gov record NCT01566162. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 12-week, multi-center, open-label extension study designed to evaluate the longer-term safety, tolerability and effectiveness of lurasidone for the treatment of subjects with schizophrenia.

Study identification

NCT ID
NCT01566162
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
191 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2012
Primary completion
Oct 31, 2013
Completion
Oct 31, 2013
Last update posted
Apr 8, 2019

2012 – 2013

United States locations

U.S. sites
38
U.S. states
15
U.S. cities
34
Facility City State ZIP Site status
K and S Professional Research Services Little Rock Arkansas 72201
Woodland International Research Inc. Little Rock Arkansas 72211
Comprehensive Clinical Development Inc. Cerritos California 90703
Diligent Clinical Trials Downey California 90241
Synergy Clinical Research Center Escondido California 92025
CNS Network Garden Grove California 92845
AXIS Clinical Trials Los Angeles California 90036
Synergy Clinical Research Center National City California 91950
Excell Research, Inc. Oceanside California 92056
CNRI-Los Angeles. LLC Pico Rivera California 90660
California Neuropsychopharmacolgoy Clinical Research Insitute San Diego California 92126
Neuropsychiatric Research Center of Orange County Santa Ana California 92701
Collaborative Neuroscience Network Torrance California 90502
Florida Clinical Research Center, LLC Bradenton Florida 34208
Accurate Clinical Trials Kissimmee Florida 34742
Galiz Research Miami Springs Florida 33166
Medical Research Group of Central Florida Orange City Florida 32763
Atlanta Center for Medical Research Atlanta Georgia 30308
Comprehensive NeuroScience Inc. Atlanta Georgia 30328
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70601
Lousiana Clinical Research, LLC Shreveport Louisiana 71104
Center for Behavioral Health, LLC Rockville Maryland 20850
Psychiatric Care and Research Center O'Fallon Missouri 63368
Psych Care Consultants Research St Louis Missouri 63128
Robert Lynn Horne, MD Las Vegas Nevada 89102
CRI Worldwide LLC Willingboro New Jersey 08046
Erie County Medical Center, Corp Buffalo New York 14215
Neurobehavioral Research Inc. Cedarhurst New York 11516
Comprehensive Clinical Development, Inc Fresh Meadows New York 11366
Finger Lakes Clinical Research Rochester New York 14618
Oklahoma Clinical Research Oklahoma City Oklahoma 73116
CRI Worldwide LLC at Kirkbride Philadelphia Pennsylvania 19139
Lincoln Research Lincoln Rhode Island 02865
Community Clinical Research, Inc. Austin Texas 78754
FutureSearch Clinical Trials LP Austin Texas 78756
FutureSearch Clinical Trials, LP Dallas Texas 75231
Pillar Clinical Research, LLC Dallas Texas 75243
Department of Psychiatry, University of Utah Health Sciences Center Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01566162, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2019 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01566162 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →